Clinical trials in New Orleans, LA

98 recruiting studies have a site in or near New Orleans, LA, Louisiana.

Top conditions here

All conditions

Showing 40 of 98 studies

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Baton Rouge, LA · +452 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Alexandria, LA · Baton Rouge, LA · +1147 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

New Orleans, LA · +113 more sites

RecruitingPhase 3NCT06498635

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Sponsor: National Cancer Institute (NCI)

New Orleans, LA · +280 more sites

RecruitingPhase not listedNCT06297291

Global Paradise System US Post Approval Study

Sponsor: ReCor Medical, Inc.

New Orleans, LA · +45 more sites

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

New Orleans, LA · +202 more sites

RecruitingPhase 3NCT07674654

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Chalmette, LA · New Orleans, LA · +111 more sites

RecruitingPhase 3NCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sponsor: UCB Biopharma SRL

Baton Rouge, LA · Lake Charles, LA · New Orleans, LA · +60 more sites

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

Hammond, LA · Lafayette, LA · Metairie, LA · +270 more sites

RecruitingPhase 3NCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Sponsor: Pfizer

New Orleans, LA · +55 more sites

RecruitingPhase 3NCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Sponsor: Novartis Pharmaceuticals

Lake Charles, LA · New Orleans, LA · +23 more sites

RecruitingPhase 3NCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Sponsor: AstraZeneca

Alexandria, LA · New Orleans, LA · Shreveport, LA · +163 more sites

RecruitingPhase 3NCT06307665

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Sponsor: AstraZeneca

Lafayette, LA · New Orleans, LA · +117 more sites

RecruitingNot applicableNCT06511141

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Sponsor: Axonics, Inc.

New Orleans, LA · Shreveport, LA · +21 more sites

RecruitingPhase 3NCT06736574

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Sponsor: Cytokinetics

New Orleans, LA · +87 more sites

RecruitingPhase 3NCT06966700

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Sponsor: Merck Sharp & Dohme LLC

New Orleans, LA · Shreveport, LA · +62 more sites

RecruitingPhase 3NCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Sponsor: Bristol-Myers Squibb

Covington, LA · Lake Charles, LA · Metairie, LA · +119 more sites

RecruitingPhase 1NCT07310420

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Sponsor: TerSera Therapeutics LLC

New Orleans, LA · +25 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

New Orleans, LA · +43 more sites

RecruitingPhase not listedNCT06750731

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Sponsor: Mercy Medical Center

New Orleans, LA · +5 more sites

RecruitingPhase 3NCT06822738

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Sponsor: AbbVie

New Orleans, LA · +28 more sites

RecruitingPhase not listedNCT07143669

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Sponsor: Blueprint Medicines Corporation

New Orleans, LA · +24 more sites

RecruitingNot applicableNCT06812533

Alleviant ALLAY-HFrEF Study

Sponsor: Alleviant Medical, Inc.

Houma, LA · New Orleans, LA · +38 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

New Orleans, LA · +111 more sites

RecruitingPhase 2NCT06570798

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Sponsor: Amgen

New Orleans, LA · +17 more sites

RecruitingPhase 1NCT06784193

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Sponsor: Olema Pharmaceuticals, Inc.

New Orleans, LA · +12 more sites

RecruitingPhase not listedNCT05334069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Sponsor: Alliance for Clinical Trials in Oncology

Baton Rouge, LA · +744 more sites

RecruitingPhase 2NCT05673148

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Sponsor: Alliance for Clinical Trials in Oncology

New Orleans, LA · +187 more sites

RecruitingPhase 2NCT06680830

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Sponsor: Neuron23 Inc.

New Orleans, LA · +44 more sites

RecruitingPhase 2NCT07142356

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Sponsor: Retension Pharmaceuticals. Inc.

New Orleans, LA · +33 more sites

RecruitingNot applicableNCT07283939

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Sponsor: Alliance for Clinical Trials in Oncology

Covington, LA · New Orleans, LA · +358 more sites

RecruitingNot applicableNCT06133322

Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

Sponsor: Tulane University

New Orleans, LA

RecruitingPhase 3NCT05835310

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Sponsor: AstraZeneca

New Orleans, LA · +21 more sites

RecruitingPhase 3NCT07221851

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Sponsor: Ascendis Pharma A/S

New Orleans, LA · +22 more sites

RecruitingPhase 2NCT07551596

Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial

Sponsor: National Cancer Institute (NCI)

New Orleans, LA · +1 more sites

RecruitingPhase 3NCT07277231

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Sponsor: BeOne Medicines

New Orleans, LA · +21 more sites

RecruitingPhase 2NCT07463183

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Sponsor: Merck Sharp & Dohme LLC

New Orleans, LA · +10 more sites

RecruitingPhase 3NCT07761117

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Sponsor: AstraZeneca

Bossier City, LA · Covington, LA · Lafayette, LA · +117 more sites

RecruitingPhase 3NCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Sponsor: Pfizer

New Orleans, LA · Shreveport, LA · +167 more sites

RecruitingPhase 3NCT04743141

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Sponsor: Pfizer

New Orleans, LA · +114 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.